Literature DB >> 12064349

Inhibition of the mitochondrial respiratory chain by phenylalanine in rat cerebral cortex.

Virginia Cielo Rech1, Luciane Rosa Feksa, Carlos Severo Dutra-Filho, Angela Terezinha de Souza Wyse, Moacir Wajner, Clovis Milton Duval Wannmacher.   

Abstract

Phenylketonuria (PKU) is biochemically characterized by the accumulation of phenylalanine (Phe) and its metabolites in tissues of affected children. Neurological damage is the clinical hallmark of PKU, and Phe is considered the main neurotoxic metabolite in this disorder. However, the mechanisms of neurotoxicity are poorly known. The main objective of the present work was to measure the activities of the mitochondrial respiratory chain complexes (RCC) and succinate dehydrogenase (SDH) in brain cortex of Wistar rats subjected to chemically induced hyperphenylalaninemia (HPA). We also investigated the in vitro effect of Phe on SDH and RCC activities in the cerebral cortex of 22-day-old rats. HPA was induced by subcutaneous administration of 2.4 micromol/g body weight alpha-methylphenylalanine, a phenylalanine hydroxylase inhibitor, once a day, plus 5.2 microM/g body weight phenylalanine, twice a day, from the 6th-21st postnatal day. The results showed a reduction of SDH and complex I + III activity in brain cortex of rats subjected to HPA. We also verified that Phe inhibited the in vitro activity of complexes I + III, possibly by competition with NADH. Considering the importance of SDH and RCC for the maintenance of energy supply to brain, our results suggest that energy deficit may contribute to the Phe neurotoxicity in PKU.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064349     DOI: 10.1023/a:1015529511664

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  Neuropathologic aspects of cytochrome C oxidase deficiency.

Authors:  K Tanji; E Bonilla
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

2.  Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates.

Authors:  L Massieu; P Del Río; T Montiel
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

3.  Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease.

Authors:  C Chinopoulos; V Adam-Vizi
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

4.  Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase.

Authors:  S Pitkanen; B H Robinson
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 5.  Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.

Authors:  A H Schapira
Journal:  Biochim Biophys Acta       Date:  1999-02-09

6.  Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation.

Authors:  B Ferger; O Eberhardt; P Teismann; C de Groote; J B Schulz
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

Review 7.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

8.  Antioxidant status in hyperphenylalaninemia.

Authors:  C Sierra; M A Vilaseca; D Moyano; N Brandi; J Campistol; N Lambruschini; F J Cambra; R Deulofeu; A Mira
Journal:  Clin Chim Acta       Date:  1998-08-10       Impact factor: 3.786

9.  Evidence for the existence of two classes of sulfhydryl groups essential for membrane-bound succinate dehydrogenase activity.

Authors:  K Lê-Quôc; D Lê-Quôc; Y Gaudemer
Journal:  Biochemistry       Date:  1981-03-31       Impact factor: 3.162

10.  Effect of phenylalanine and alpha-methylphenylalanine on in vitro incorporation of 32P into cytoskeletal cerebral proteins.

Authors:  M S de Freitas; A G de Mattos; M M Camargo; C M Wannmacher; R Pessoa-Pureur
Journal:  Neurochem Int       Date:  1995-04       Impact factor: 3.921

View more
  19 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 2.  Antioxidant treatment strategies for hyperphenylalaninemia.

Authors:  Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-05-09       Impact factor: 3.584

Review 3.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

4.  In-silico and in-vitro investigation on the phenylalanine metabolites' interactions with hexokinase of Rat's brain mitochondria.

Authors:  Nasrin Ziamajidi; Shirin Jamshidi; Abdolvahab Ehsani-Zonouz
Journal:  J Bioenerg Biomembr       Date:  2017-03-08       Impact factor: 2.945

5.  Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats.

Authors:  Simone Luisa Berti; Guilherme Marmontel Nasi; Cristina Garcia; Fernanda Luz de Castro; Michely Lopes Nunes; Denise Bertin Rojas; Tarsila Barros Moraes; Carlos Severo Dutra-Filho; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2011-11-19       Impact factor: 3.584

6.  Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.

Authors:  Vanessa Trindade Bortoluzzi; Letícia Brust; Thales Preissler; Itiane Diehl de Franceschi; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2019-07-27       Impact factor: 3.584

Review 7.  Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations.

Authors:  Patrícia Fernanda Schuck; Fernanda Malgarin; José Henrique Cararo; Fabiola Cardoso; Emilio Luiz Streck; Gustavo Costa Ferreira
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

8.  Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients.

Authors:  I P Hargreaves; S J R Heales; A Briddon; J M Land; P J Lee
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

9.  Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.

Authors:  Carolina G Fernandes; Guilhian Leipnitz; Bianca Seminotti; Alexandre U Amaral; Angela Zanatta; Carmen R Vargas; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2009-09-23       Impact factor: 5.046

10.  Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia.

Authors:  N Kyprianou; E Murphy; P Lee; I Hargreaves
Journal:  J Inherit Metab Dis       Date:  2009-03-13       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.